Skip to main content

Table 3 Bone markers

From: Effect of simvastatin on bone markers in osteopenic women: a placebo-controlled, dose-ranging trial [ISRCTN85429598]

 

Placebo

Simvastatin 20

Simvastatin 40

 

Baseline

6 weeks

12 weeks

Baseline

6 weeks

12 weeks

Baseline

6 weeks

12 weeks

NTX-I, nM BCE

15.5 ± 1.8

15.7 ± 2.0

15.9 ± 1.4

16.5 ± 1.7

15.9 ± 1.2

19.6 ± 1.8

19.3 ± 2.4

17.6 ± 2.1

18.1 ± 2.0

CTX-I, ng/ml

95.4 ± 5.9

86.4 ± 7.9

86.9 ± 11.5

90.3 ± 10.1

83.2 ± 12.1

107.2 ± 18.8

108.2 ± 11.3

94.2 ± 14.1

120.7 ± 12.2

Bone ALP, U/L

14.3 ± 2.4

14.0 ± 2.5

14.4 ± 2.9

19.0 ± 3.0

17.4 ± 2.8

17.2 ± 2.8

14.3 ± 2.2

13.4 ± 2.2

14.0 ± 2.2

  1. Mean + SE